Inventor
SAJJA ESWARAIAH
IN17 patents
⚠️ This page may combine multiple inventors who share the name “SAJJA ESWARAIAH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MSN LABORATORIES PRIVATE LTD R&D CENTER
9 patentsUS11261160B2Mar 1, 2022
Process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide, (2S)-hydroxybutanedioate and its polymorphs thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER9 citations80
US10913717B2Feb 9, 2021
Solid state forms of N-[2-[(I S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methyl sulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-L H-isoindol-4-yl]acetamide and process for preparation thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations56
US11236050B2Feb 1, 2022
Polymorphs of 4-[3-chloro-4-(n′-cyclopropyl ureido)phenoxy] -7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations55
US12227506B2Feb 18, 2025
Crystalline polymorphs of 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one and process for preparation thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations54
US12227518B2Feb 18, 2025
Crystalline polymorphs of sodium (4R,12AS)-9-{[(2,4-difluorophenyl) methyl]carbamoyl}-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido [1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-7-olate and process for preparation thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations54
US11434256B2Sep 6, 2022
Process for the preparation of 3α,7α-dihydroxy-6α-ethyl-5β-cholan-24-oic acid
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations54
US11149026B2Oct 19, 2021
Solid state forms of 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione hydrochloride and their processes for the preparation thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations54
US12473292B2Nov 18, 2025
Polymorphs of 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]-amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide and its pharmaceutically acceptable salts and process for the preparation thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations52
US10865217B2Dec 15, 2020
Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereof
MSN LABORATORIES PRIVATE LTD R&D CENTER0 citations34
MSN LABORATORIES PRIVATE LTD
5 patentsUS10550107B2Feb 4, 2020
Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereof
MSN LABORATORIES PRIVATE LTD3 citations69
US11279696B2Mar 22, 2022
Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one
MSN LABORATORIES PRIVATE LTD0 citations55
US10544097B2Jan 28, 2020
Solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide and process for preparation thereof
MSN LABORATORIES PRIVATE LTD0 citations46
US10913762B2Feb 9, 2021
Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof
MSN LABORATORIES PRIVATE LTD0 citations45
US10703731B2Jul 7, 2020
Process for the preparation of Trisodium (4- {[1S,3R)-1-([1,1′-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(N-petanoyl-N-{[2′-(1H-tetrazol-1-1D-5-yl)[1,1′-biphenyl]-4-yl]methyl}- L-valinate) and its polymorphs thereof
MSN LABORATORIES PRIVATE LTD0 citations32